Literature DB >> 11408839

Outcome predictors in anorectic patients after 6 months of multimodal treatment.

S Fassino1, G Abbate Daga, F Amianto, P Leombruni, B Fornas, L Garzaro, G D'Ambrosio, G G Rovera.   

Abstract

BACKGROUND: Anorexia nervosa is a severe disorder that often responds poorly to treatment. At this time, little is known about pretreatment predictors of response.
METHODS: A sample of 42 restrictor type anorectics was tested at the assessment phase and after 180 days retested using the Temperament and Character Inventory and Eating Disorder Inventory 2 along with other clinical evaluation instruments. After 180 days of treatment with multimodal 'network' therapy, the patients were divided into two groups. The first group included patients who showed relevant clinical improvement; the second group included patients considered 'not yet responding'. Data collected from the not-yet-responding group were compared by the t test with the other group's data to evaluate prognostic indexes.
RESULTS: Diagnosis of personality disorder, which afflicted about 50% of patients, seemed not to be a relevant prognostic factor. However, a lower novelty seeking was characteristic of the nonresponder group. Higher levels of asceticism and maturity fears also characterized the nonresponder group.
CONCLUSION: Present data suggest some elements that could be useful to focus pharmacotherapy, psychotherapy and family counseling on the current psychopathology of each patient. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408839     DOI: 10.1159/000056254

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  9 in total

1.  A Spanish version of the Family Assessment Device.

Authors:  Sergio Barroilhet; Adrián Cano-Prous; Salvador Cervera-Enguix; Maria João Forjaz; Francisco Guillén-Grima
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-14       Impact factor: 4.328

Review 2.  Day hospital programmes for eating disorders: a review of the similarities, differences and goals.

Authors:  G Abbate-Daga; C Gramaglia; S Preda; E Comba; A Brustolin; S Fassino
Journal:  Eat Weight Disord       Date:  2009 Jun-Sep       Impact factor: 4.652

Review 3.  A comprehensive review of psychodynamic treatments for eating disorders.

Authors:  Giovanni Abbate-Daga; Enrica Marzola; Federico Amianto; Secondo Fassino
Journal:  Eat Weight Disord       Date:  2016-03-15       Impact factor: 4.652

4.  Adlerian parental counseling in eating disorders: preliminary data of a controlled clinical trial.

Authors:  Federico Amianto; Antonella Bertorello; Angela Spalatro; Marina Milazzo; Caterina Signa; Silvia Cavarero; Giovanni Abbate Daga; Secondo Fassino
Journal:  Eat Weight Disord       Date:  2013-10-24       Impact factor: 4.652

5.  Baseline personality characteristics of responders to 6-month psychotherapy in eating disorders: preliminary data.

Authors:  S Fassino; G Abbate Daga; N Delsedime; F Busso; A Pierò; G G Rovera
Journal:  Eat Weight Disord       Date:  2005-03       Impact factor: 4.652

Review 6.  Temperament and character in eating disorders: ten years of studies.

Authors:  S Fassino; F Amianto; C Gramaglia; F Facchini; G Abbate Daga
Journal:  Eat Weight Disord       Date:  2004-06       Impact factor: 4.652

7.  Outcome predictors in the short-term treatment of anorexia nervosa: an integrated medical-psychiatric approach.

Authors:  A Signorini; O Bellini; F Pasanisi; F Contaldo; E De Filippo
Journal:  Eat Weight Disord       Date:  2003-06       Impact factor: 4.652

8.  Temperamental factors predict long-term modifications of eating disorders after treatment.

Authors:  Cristina Segura-García; Dora Chiodo; Flora Sinopoli; Pasquale De Fazio
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

9.  Resistance to treatment and change in anorexia nervosa [corrected]: a clinical overview.

Authors:  Giovanni Abbate-Daga; Federico Amianto; Nadia Delsedime; Carlotta De-Bacco; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.